Genesco, Inc. (GCO) Tops Q3 EPS Views; Raises FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts GCO Hot Sheet
Price: $34.55 -3.52%
Revenue Growth %: +0.2%
Financial Fact:
Provision for discontinued operations, net: -53K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +0.2%
Financial Fact:
Provision for discontinued operations, net: -53K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Genesco, Inc. (NYSE: GCO) reported Q3 EPS of $1.21, $0.25 better than the analyst estimate of $0.96. Revenue for the quarter came in at $616.5 million versus the consensus estimate of $586.25 million.
Genesco, Inc. sees FY2012 EPS of $3.64-$3.69, versus prior guidance of $3.35-$3.42 and the consensus of $3.44.
Genesco, Inc. sees FY2012 EPS of $3.64-$3.69, versus prior guidance of $3.35-$3.42 and the consensus of $3.44.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genesco (GCO) Tops Q2 EPS by 54c ; Offers Guidance
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- Oxford Industries (OXM) Tops Q2 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
